Literature DB >> 10082092

Generalized periodic epileptiform discharges: etiologies, relationship to status epilepticus, and prognosis.

A M Husain1, K A Mebust, R A Radtke.   

Abstract

Generalized periodic epileptiform discharges (GPEDs) are generalized, synchronous electrographic discharges. This study investigates etiologies, relationship to status epilepticus (SE), and the prognosis for patients with GPEDs. All EEGs with GPEDs performed at Duke University Medical Center between January 1994 and October 1995 were identified. Clinical histories and EEGs were reviewed. They were divided into groups depending on the etiology of the GPEDs, whether the patients were in SE or not, and whether they were alive or not at discharge. A comparison of histories and GPED characteristics among groups was undertaken using parametric and nonparametric t tests. Twenty-five patients were enrolled: 7 (28%) had toxic-metabolic encephalopathy, 10 (40%) had anoxia and toxic-metabolic encephalopathy, and 8 (32%) had a primary neurologic process. Eight patients (32%) were in SE. In the SE group, GPED amplitude was higher (110 versus 80 microV, P < 0.05), GPED duration was longer (0.5 versus 0.3 seconds, P < 0.05), and inter-GPED amplitude was higher (34 versus 17 microV, P < 0.05). Nine patients (36%) were alive at discharge; they were more likely to be younger (51 versus 68 years, P < 0.05), have a better mental status at the time of their EEG, and have a higher inter-GPED amplitude (33 versus 18 microV, P < 0.05). A variety of conditions, including SE, can cause GPEDs. Intergroup differences in historic and GPED features exist between those patients in SE and those not in SE and those with good and poor prognoses.

Entities:  

Mesh:

Year:  1999        PMID: 10082092     DOI: 10.1097/00004691-199901000-00005

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  16 in total

Review 1.  The utility of EEG, SSEP, and other neurophysiologic tools to guide neurocritical care.

Authors:  Eric S Rosenthal
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 2.  Continuous electroencephalogram monitoring in the critically ill.

Authors:  John J Wittman; Lawrence J Hirsch
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage.

Authors:  Jan Claassen; Lawrence J Hirsch; Jennifer A Frontera; Andres Fernandez; Michael Schmidt; Gregory Kapinos; John Wittman; E Sander Connolly; Ronald G Emerson; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

4.  Epilepsy: Does continuous EEG monitoring improve seizure control?

Authors:  Ronald P Lesser
Journal:  Nat Rev Neurol       Date:  2009-11       Impact factor: 42.937

Review 5.  The Ictal-Interictal Continuum: To Treat or Not to Treat (and How)?

Authors:  Clio Rubinos; Alexandra S Reynolds; Jan Claassen
Journal:  Neurocrit Care       Date:  2018-08       Impact factor: 3.210

Review 6.  Ictal Interictal Continuum Patterns.

Authors:  Gamaleldin M Osman; Davi F Araújo; Carolina B Maciel
Journal:  Curr Treat Options Neurol       Date:  2018-04-18       Impact factor: 3.598

7.  Impact of prolonged periodic epileptiform discharges on coma prognosis.

Authors:  Charlene Ong; Emily Gilmore; Jan Claassen; Brandon Foreman; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

Review 8.  Diagnosis and treatment of nonconvulsive status epilepticus.

Authors:  M C Walker
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

9.  Generalized periodic discharges in the critically ill: a case-control study of 200 patients.

Authors:  Brandon Foreman; Jan Claassen; Karine Abou Khaled; Jeffrey Jirsch; Daniel M Alschuler; John Wittman; Ronald G Emerson; Lawrence J Hirsch
Journal:  Neurology       Date:  2012-10-03       Impact factor: 9.910

Review 10.  Nonconvulsive status with metronidazole.

Authors:  A A Cantador; J F Meschia; W D Freeman; W O Tatum
Journal:  Neurohospitalist       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.